Warning: mkdir(): No space left on device in /var/www/tgoop/post.php on line 37

Warning: file_put_contents(aCache/aDaily/post/CIP_USERN/--): Failed to open stream: No such file or directory in /var/www/tgoop/post.php on line 50
CIP, Cancer Immunology Project@CIP_USERN P.169
CIP_USERN Telegram 169
tgoop.com » United States » CIP, Cancer Immunology Project » Telegram web » Post 169
CIP, Cancer Immunology Project
Forwarded from NIIMA, Network of Immunity in Infection, Malignancy and Autoimmunity
Development and clinical application of bispecific antibody in the treatment of colorectal cancer

New paper by USERN interest groups

🌀Treatment of colorectal cancer as one of the most commonly diagnosed and a frequent cause of cancer-related deaths is of great challenges in health-related issues.

🌀Immunotherapy is the fourth pillar of cancer treatment which provides more novel therapeutic options with expanding investigational potentials.

🌀One of the modalities in immunotherapy is the use of bispecific antibodies. Despite demonstrating many promising roles, it still needs more advanced studies to identify the actual pros and cons.

🌀In this review, the application of bispecific antibody in the treatment of colorectal cancer has been explained, based on preclinical and clinical studies.

🌀Bispecific antibody is in its early stages in colorectal cancer treatment.

Source: https://doi.org/10.1080/1744666X.2020.1783249

#Paper
#USERN

@niima_usern
@cip_usern
@usern_net
www.tgoop.com/CIP_USERN/169
124 views



tgoop.com/CIP_USERN/169
Create:
Last Update:

Development and clinical application of bispecific antibody in the treatment of colorectal cancer

New paper by USERN interest groups

🌀Treatment of colorectal cancer as one of the most commonly diagnosed and a frequent cause of cancer-related deaths is of great challenges in health-related issues.

🌀Immunotherapy is the fourth pillar of cancer treatment which provides more novel therapeutic options with expanding investigational potentials.

🌀One of the modalities in immunotherapy is the use of bispecific antibodies. Despite demonstrating many promising roles, it still needs more advanced studies to identify the actual pros and cons.

🌀In this review, the application of bispecific antibody in the treatment of colorectal cancer has been explained, based on preclinical and clinical studies.

🌀Bispecific antibody is in its early stages in colorectal cancer treatment.

Source: https://doi.org/10.1080/1744666X.2020.1783249

#Paper
#USERN

@niima_usern
@cip_usern
@usern_net

BY CIP, Cancer Immunology Project




Share with your friend now:
tgoop.com/CIP_USERN/169

View MORE
Open in Telegram


Telegram News

Date: |

There have been several contributions to the group with members posting voice notes of screaming, yelling, groaning, and wailing in different rhythms and pitches. Calling out the “degenerate” community or the crypto obsessives that engage in high-risk trading, Co-founder of NFT renting protocol Rentable World emiliano.eth shared this group on his Twitter. He wrote: “hey degen, are you stressed? Just let it out all out. Voice only tg channel for screaming”. 4How to customize a Telegram channel? Administrators How to build a private or public channel on Telegram? How to Create a Private or Public Channel on Telegram?
from us



Warning: filemtime(): stat failed for aCache/aDaily/post/CIP_USERN/-- in /var/www/tgoop/post.php on line 323

Warning: filemtime(): stat failed for aCache/aDaily/post/CIP_USERN/-- in /var/www/tgoop/post.php on line 324

Development and clinical application of bispecific antibody in the treatment of colorectal cancer

 CIP, Cancer Immunology Project TG
web: 169
CIP, Cancer Immunology Project.Telegram web
CIP, Cancer Immunology Project Telegram TG Channel
Telegram Updated:
Telegram CIP, Cancer Immunology Project
FROM American